Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by archeo753on Feb 09, 2022 6:58am
134 Views
Post# 34411310

RE:Another hypothetical

RE:Another hypotheticalMDGL had a very muted response to their latest PH 3 results in the first 2 days after the press release.  Since then, however, they have had a very impressive multi day share price gain which hasn't yet run out of steam.  Hard to predict what could happen to TH with good news but might be worth holding on a little longer to maximize gains.


SS1316 wrote:

TH seems to always sell off on any positive SP movement, seems as though investors are looking to cash in on their patients even if they're just scalping.  

'Hypothetical scenario' if the positive news that we are all imagining for the 1a trial comes through to break TH's deafening scilence annnd the market somehow notices it annnd has a positive response,  let's just say a 55% gain over a couple trading days, how quick does it sell off? 

Only a hypothetical question, I'm defiantly not over leveraged here. 



<< Previous
Bullboard Posts
Next >>